Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?

Zachary Bloomgarden

Research output: Contribution to journal › Editorial

5 Scopus citations

Original language	English
Pages (from-to)	712-713
Number of pages	2
Journal	Journal of Diabetes
Volume	15
Issue number	9
DOIs	https://doi.org/10.1111/1753-0407.13469
State	Published - Sep 2023

Access to Document

10.1111/1753-0407.13469

Cite this

@article{401f06a27d1442e7a3855b2560d9b7b7,

title = "Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?",

author = "Zachary Bloomgarden",

year = "2023",

month = sep,

doi = "10.1111/1753-0407.13469",

language = "English",

volume = "15",

pages = "712--713",

journal = "Journal of Diabetes",

issn = "1753-0393",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?

AU - Bloomgarden, Zachary

PY - 2023/9

Y1 - 2023/9

UR - http://www.scopus.com/inward/record.url?scp=85171479314&partnerID=8YFLogxK

U2 - 10.1111/1753-0407.13469

DO - 10.1111/1753-0407.13469

M3 - Editorial

C2 - 37727016

AN - SCOPUS:85171479314

SN - 1753-0393

VL - 15

SP - 712

EP - 713

JO - Journal of Diabetes

JF - Journal of Diabetes

IS - 9

ER -